Chimeric TK-NOG Mice: A Predictive Model for Cholestatic Human Liver Toxicity

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Journal of Pharmacology and Experimental Therapeutics

• Publication date

  2015-02-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1124/jpet.114.220798PMID 25424997PMCID PMC4293443
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Fialuridine Induces Acute Liver Failure in Chimeric TK-NOG Mice: A Model for Detecting Hepatic Drug Toxicity Prior to Human Testing

  2014influential reference
• Can 'humanized' mice improve drug development in the 21st century?

  2013influential reference
• Using Chimeric Mice with Humanized Livers to Predict Human Drug Metabolism and a Drug-Drug Interaction

  2013cited by this paper
• Human pharmacogenetic analysis in chimeric mice with ‘humanized livers’

  2013influential reference
• Effect of bile duct ligation on bile acid composition in mouse serum and liver

  2012cited by this paper
• The reconstituted 'humanized liver' in TK-NOG mice is mature and functional.

  2011influential reference
• In Silico Prediction of Biliary Excretion of Drugs in Rats Based on Physicochemical Properties

  2010cited by this paper
• Reporting : The ARRIVE Guidelines for Reporting Animal Research

  2010cited by this paper
• Which human metabolites have we MIST? Retrospective analysis, practical aspects, and perspectives for metabolite identification and quantification in pharmaceutical development.

  2009cited by this paper
• Predicting circulating human metabolites: how good are we?

  2009cited by this paper
• A holistic strategy for characterizing the safety of metabolites through drug discovery and development.

  2009cited by this paper
• PhRMA White Paper on ADME Pharmacogenomics

  2008cited by this paper
• Results of European post-marketing surveillance of bosentan in pulmonary hypertension

  2007cited by this paper
• Humanization of excretory pathway in chimeric mice with humanized liver.

  2007cited by this paper
• Bosentan Is a Substrate of Human OATP1B1 and OATP1B3: Inhibition of Hepatic Uptake as the Common Mechanism of Its Interactions with Cyclosporin A, Rifampicin, and Sildenafil

  2007cited by this paper
• Inhibitory and Inductive Effects of Rifampin on the Pharmacokinetics of Bosentan in Healthy Subjects

  2007cited by this paper
• Effects of bosentan, an endothelin receptor antagonist, on bile salt export pump and multidrug resistance–associated protein 2

  2007cited by this paper
• The Important Role of Bcrp (Abcg2) in the Biliary Excretion of Sulfate and Glucuronide Metabolites of Acetaminophen, 4-Methylumbelliferone, and Harmol in Mice

  2006cited by this paper
• Kinetic validation of the use of carboxydichlorofluorescein as a drug surrogate for MRP5-mediated transport.

  2006cited by this paper
• Drug‐induced liver injury: Summary of a single topic clinical research conference

  2006cited by this paper
• Pharmacokinetics of 5 (and 6)-Carboxy-2′,7′-Dichlorofluorescein and Its Diacetate Promoiety in the Liver

  2003cited by this paper
• The enzymes, regulation, and genetics of bile acid synthesis.

  2003cited by this paper
• The European Federation for Pharmaceutical Sciences

  2003cited by this paper
• Bosentan therapy for pulmonary arterial hypertension.

  2002cited by this paper
• BOSENTAN THERAPY FOR PULMONARY ARTERIAL HYPERTENSION

  2002cited by this paper
• Results of a Prospective Study of Acute Liver Failure at 17 Tertiary Care Centers in the United States

  2002influential reference
• Contribution of mrp2 in alterations of canalicular bile formation by the endothelin antagonist bosentan.

  2002influential reference
• The endothelin antagonist bosentan inhibits the canalicular bile salt export pump: A potential mechanism for hepatic adverse reactions

  2001influential reference
• Bile acid synthesis and biliary hydrophobicity during obstructive jaundice in rats.

  1996influential reference
• Review of the Fialuridine (FIAU) Clinical Trials

  1995cited by this paper
• Controlling the false discovery rate: a practical and powerful approach to multiple testing

  1995cited by this paper
• Hepatic failure and lactic acidosis due to fialuridine (FIAU), an investigational nucleoside analogue for chronic hepatitis B.

  1995cited by this paper
• Regulation of cholesterol and bile acid homoeostasis in bile-obstructed rats.

  1991cited by this paper
• Effect of bile duct ligation on bile acid and cholesterol metabolism in rats.

  1988cited by this paper

• Humanized liver mouse models in preclinical drug development: current status, translation challenges and emerging technologies.

  2026cites this paper
• Analysis of the Bile Acid Composition in a Fibroblast Growth Factor 19-Expressing Liver-Humanized Mouse Model and Its Use for CYP3A4-Mediated Drug–Drug Interaction Studies

  2023cites this paper
• Modeling drug-induced liver injury: current status and future prospects

  2022cites this paper
• Utility of Göttingen minipigs for the prediction of human pharmacokinetic profiles after intravenous drug administration.

  2021cites this paper
• Bosentan Alters Endo- and Exogenous Bile Salt Disposition in Sandwich-Cultured Human Hepatocytes

  2021cites this paper
• Advancements in stem cell-derived hepatocyte-like cell models for hepatotoxicity testing

  2021cites this paper
• Preclinical models of idiosyncratic drug-induced liver injury (iDILI): Moving towards prediction

  2021cites this paper
• Art of Making Artificial Liver: Depicting Human Liver Biology and Diseases in Mice

  2020cites this paper
• Metabolism of desloratadine by chimeric TK-NOG mice transplanted with human hepatocytes

  2020cites this paper
• [Recent advances in evaluation studies for drug-induced liver injury].

  2020cites this paper
• Characterization of plasma protein binding in two mouse models of humanized liver, PXB mouse and humanized TK-NOG mouse

  2020cites this paper
• Drug Induced Liver Injury (DILI). Mechanisms and Medicinal Chemistry Avoidance/Mitigation Strategies.

  2020cites this paper
• Reconstituted Human Organ Models as a Translational Tool for Human Organ Response: Definition, Expectations, Cases, and Strategies for Implementation in Drug Discovery and Development.

  2020cites this paper
• Understanding Idiosyncratic Toxicity: Lessons Learned from Drug-Induced Liver Injury.

  2020cites this paper
• Application of genetically modified rodent models in drug discovery and development for translation of clinical ADME properties

  2020cites this paper
• Detection of acute toxicity of aflatoxin B1 to human hepatocytes in vitro and in vivo using chimeric mice with humanized livers

  2020cites this paper
• Attenuated P. falciparum Parasite Shows Cytokine Variations in Humanized Mice

  2020cites this paper
• Establishment of the Dual Humanized TK-NOG Mouse Model for HIV-associated Liver Pathogenesis.

  2019cites this paper
• Changes in Bile Acid Concentrations in Chimeric Mice Transplanted with Different Replacement Indexes of Human Hepatocytes

  2019cites this paper
• Changes in Bile Acid Concentrations in Chimeric Mice Transplanted with Different Replacement Indexes of Human Hepatocytes

  2019cites this paper
• Humanized mouse models for human viral hepatitis and related liver diseases

  2019cites this paper
• Changes in Bile Acid Concentrations after Administration of Ketoconazole or Rifampicin to Chimeric Mice with Humanized Liver.

  2019cites this paper
• Predicting drug-induced cholestasis: preclinical models

  2018cites this paper
• Humanized mice: A brief overview on their diverse applications in biomedical research

  2018cites this paper
• [Contribution of chimeric mice with a humanized liver to the evaluation of pharmacology, toxicity, and pharmacokinetics in drug discovery and development].

  2018cites this paper
• P450-Humanized and Human Liver Chimeric Mouse Models for Studying Xenobiotic Metabolism and Toxicity

  2018cites this paper
• Biomedical applications of nanofibrillar cellulose

  2018cites this paper
• CYP-humanized and Human Liver Chimeric Mouse Models for Studying Xenobiotic Metabolism and Toxicity

  2018cites this paper
• Evaluating the regenerative potential and functionality of human liver cells in mice.

  2017cites this paper
• Chimeric mice with humanized liver: Application in drug metabolism and pharmacokinetics studies for drug discovery.

  2017cites this paper
• Humanized Mouse Models of Clinical Disease.

  2017cites this paper
• Drug-induced liver injury: recent advances in diagnosis and risk assessment

  2017cites this paper
• Long‐enduring primary hepatocyte‐based co‐cultures improve prediction of hepatotoxicity

  2017cites this paper
• Disrupted Murine Gut–to–Human Liver Signaling Alters Bile Acid Homeostasis in Humanized Mouse Liver Models

  2017cites this paper
• Recapitulation of treatment response patterns in a novel humanized mouse model for chronic hepatitis B virus infection.

  2017cites this paper
• Genetically Humanized Animal Models

  2017cites this paper
• 6.28 Liver Tissue Engineering

  2017cites this paper
• A comparison between genetically humanized and chimeric liver humanized mouse models for studies in drug metabolism and toxicity.

  2016cites this paper
• The Use of Genetically Modified Animals in Discovery Toxicology

  2016cites this paper
• New technologies in drug metabolism and toxicity screening: organ-to-organ interaction

  2016cites this paper
• Can Humanized Mice Predict Drug "Behavior" in Humans?

  2016cites this paper
• Assessment of chimeric mice with humanized livers in new drug development: generation of pharmacokinetics, metabolism and toxicity data for selecting the final candidate compound

  2016influential citation
• Functional Integrity of the Chimeric (Humanized) Mouse Liver: Enzyme Zonation, Physiologic Spaces, and Hepatic Enzymes and Transporters

  2016cites this paper
• The Promise of New Technologies to Reduce, Refine, or Replace Animal Use while Reducing Risks of Drug Induced Liver Injury in Pharmaceutical Development.

  2016cites this paper
• Assessing Concordance of Drug-Induced Transcriptional Response in Rodent Liver and Cultured Hepatocytes

  2016cites this paper
• Advances in Engineered Liver Models for Investigating Drug-Induced Liver Injury

  2016cites this paper
• Altération de la dynamique des canalicules biliaires in vitro : une nouvelle approche de la prédiction de la cholestase intrahépatique d'origine médicamenteuse

  2016cites this paper
• Drug- and herb-induced liver injury: Progress, current challenges and emerging signals of post-marketing risk.

  2015cites this paper
• Humanized Thymidine Kinase–NOG Mice Can Be Used to Identify Drugs That Cause Animal-Specific Hepatotoxicity: A Case Study with Furosemide

  2015influential citation